Key facts
- This page summarizes Julie Ann Goldstein's Form 4 filing for electroCore, Inc. (ECOR).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 10 Sep 2026, 16:05.
Julie Ann Goldstein - 09 Sep 2026 Form 4 Insider Report for electroCore, Inc. (ECOR)
- Reporting relationship
- Director
- Issuer ticker
- ECOR
- Reported as of
- 09 Sep 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 10 Sep 2026, 16:05:11 UTC
- Prior SEC filing
- 04 Sep 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ John L. Cleary, II, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Julie Ann Goldstein filed Form 4 for electroCore, Inc. (ECOR) on 10 Sep 2026.
Change
- Previous filing in this sequence was filed on 04 Sep 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001917358
Primary reporting owner
Goldstein Julie Ann
- Relationship
- Director
- Address
- 200 FORGE WAY,, SUITE 205, ROCKAWAY
- Signature
- /s/ John L. Cleary, II, attorney-in-fact
- Signature date
- 10 Sep 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ECOR
transaction
Common Stock
Award
- Transaction value
- Shares
- +11,123
- Change %
- +11%
- Price
- $0.000000*
- Shares after
- 112,510
- Date
- 09 Sep 2026
- Ownership
- Direct
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Annual Deferred Stock Units award which vests in 12 equal monthly installments from the grant date; provided, however, that the Deferred Stock Units shall vest in full on the earlier of (i) the close of business one business day prior to the Issuer's next annual stockholder meeting following the grant date, and (ii) the date immediately prior to a change of control, in each case, provided that the Reporting Person (RP) remains in continuous service with the Issuer or an affiliate through the applicable vesting date.
Footnote F2
Includes 29,011 shares that have vested pursuant to previously issued Deferred Stock Units. All such vested shares were previously reported on Form 4 filings at the time of grant.
Footnote F3
Includes 1,665 shares held in NeuroSpine Ventures; an entity in which the RP has no voting or dispositive power over the shares. Accordingly, the RP disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose.